期刊文献+

10-氯-5-二乙氧基甲基-1,3-二甲基色烯并[4,3-d]吡唑并[3,4-b]吡啶-6(3H)-酮的合成和晶体结构 被引量:1

Synthesis and crystal structure of 10-chloro-5-(diethoxymethyl)-1,3-dimethylchromeno[4,3-d]pyrazolo[3,4-b]pyridin-6(3H)-one
原文传递
导出
摘要 利用L-脯氨酸催化的5-氯水杨醛(1)与6-甲基-4-羟基吡喃酮(2)的缩合反应及硫酸铜催化下与1,3-二甲基-5-氨基吡唑(3)的串联反应,合成得到了10-氯-1,3-二甲基-5-(2-氧代丙基)色烯并[4,3-d]吡唑并[3,4-b]吡啶-6(3H)-酮(4)和10-氯-5-二乙氧基甲基-1,3-二甲基色烯并[4,3-d]吡唑并[3,4-b]吡啶-6(3H)-酮(5).化合物5的结构通过单晶X射线衍射法确定:晶体属于三斜晶系,空间群P-1;相对分子质量Mr=803.68;晶胞参数a=1.03160(10)nm,b=1.42900(13)nm,c=1.44268(15)nm;V=1.9448(3)nm^3;Z=2;晶胞密度Dc=1.372g/cm^3;吸收系数μ=0.228mm-1;单胞中电子的数目F(000)=840.晶体结构用直接法解出,经全矩阵最小二乘法对原子参数进行修正,最终的偏离因子为R=0.0681,w R=0.2051.在晶体结构中色烯环与吡啶环及吡唑环近似于共平面. 10-Chloro-1,3-dimethyl-5-(2-oxopropyl)chromeno[4,3-d]pyrazolo[3,4-b]pyridin-6(3H)-one(4) and 10-chloro-5-(diethoxymethyl)-1,3-dimethylchromeno[4,3-d]pyrazolo[3,4-b]pyridin-6(3H)-one(5) have been synthesized by the tandem reaction of 5-chloro-2-hydroxybenzaldehyde(1), 4-hydroxy-6-methyl-2H-pyran-2-one(2) and 1,3-dimethyl-1H-pyrazol-5-amine(3) catalyzed by L-proline and Cu SO4, respectively. The structure of compound 5 was determined by single crystal X-ray diffraction analysis. The crystal is triclinic, space group P-1, with Mr=803.68, a=1.031 60(10) nm, b=1.429 00(13) nm, c=1.442 68(15) nm, V=1.944 8(3) nm^3, Z=2, Dc=1.372 g/cm^3, μ=0.228 mm-1, F(000)=840. The structure was solved by direct methods and refined by full-matrix least squares method to the final R=0.068 1, w R=0.205 1. X-ray analysis reveals that the chromene ring, pyridine ring and pyrazole ring in the crystal structure are in a coplanar.
出处 《分子科学学报》 CAS CSCD 北大核心 2016年第1期83-88,共6页 Journal of Molecular Science
基金 江苏省高校自然科学重大资助项目(10KJA150049)
关键词 色烯并[4 3-d]吡唑并[3 4-b]吡啶 合成 晶体结构 chromeno[4 3-d]pyrazolo[3 4-b]pyridine synthesis crystal structure
  • 相关文献

参考文献20

  • 1WANG C G, WU C Y,ZHU J Q, et al.[J].J Med Chem,2011,54(7):2331-2340.
  • 2JUNG H S, KWON P S, LEE J W, et al.[J].J Am Chem Soc,2009,131(5):2008-2012.
  • 3CHEN J J, LI K T, YANG D Y, et al.[J].Org Lett,2011, 13(7): 1658-1661.
  • 4ZHAO Y R, ZHENG Q, DAKIN K, et al.[J].J Am Chem Soc,2004,126(14):4653-4663.
  • 5CARDOSO C R, BRITO F C F, SILVA K C M, et al.[J].Bioorg Med Chem Lett,2002,12:9212-9218.
  • 6BONDAVALLI F, BOTTA M, BRUNO O, et al.[J].J Med Chem, 2002,45(22):4875-4887.
  • 7ALLEN D G, COE D M, COOK C M, et al.Preparation of pyrazolo[3,4-b]pyridine derivativesfor use in pharmaceutical compositions as phosphodiesterase inhibitors: world, 2004056823Al [P]. 2004-07-08.
  • 8HOEHN H.Imidazolylethoxy derivatives of pyrazolo[3,4-b]pyridine-5-methanols:USA,4159380A[P]. I979-06-26.
  • 9HELGA F,UWE H.Preparation of 2-hydrazino-4, 5, 6, 7-tetrahydropyrazolo[1,5-a]pyridine from hydrazine and 1,1,7-trichloro- 1-hepten-3-one: Germany, 19613753A 1 [P]. 1997-10-02.
  • 10ERHARD N, WILFRIED F,FRIEDRICH A, et al.Preparation of imidazolylpyrazolo [3,4-b]pyridine derivatives as herbicides: Germany, 3616849A l [P]. 1987-11-19.

同被引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部